Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-02-20 @ 9:47 AM
Study NCT ID:
NCT03377556
Status:
COMPLETED
Last Update Posted:
2021-06-23
First Post:
2017-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
S1400G
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |